BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2026 6:51:58 AM | Browse: 0 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 125841
Country China
Received
2026-07-20 06:33
Peer-Review Started
2026-07-20 06:34
First Decision by Editorial Office Director
Return for Revision
2026-08-10 05:48
Revised
2026-08-22 02:49
Publication Fee Transferred
2026-09-07 10:20
Editorial Processing by Scientific Editor
2026-10-29 07:08
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-10-29 10:25
Articles in Press
2026-10-29 10:25
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-11-08 15:55
Publish the Manuscript Online
2026-11-19 06:51
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Chromatin assembly factor 1 subunit B expression correlates with favorable prognosis and potential therapeutic response prediction in left-sided colorectal cancer
Manuscript Source Unsolicited Manuscript
All Author List Xi-Jie Fan, Fu-Sheng Wang, Yuan Yao, Shun Xu, Chao-Qian Chen and Zong-Xian Zhao
ORCID
Author(s) ORCID Number
Yuan Yao http://orcid.org/0000-0003-0585-186X
Zong-Xian Zhao http://orcid.org/0000-0001-7553-2085
Funding Agency and Grant Number
Funding Agency Grant Number
Fuyang Municipal Science and Technology Bureau, Anhui, China No. FK20245505
Anhui Provincial Health Commission No. AHWJ2023Baa20164
Bengbu Medical University No. 2022byzd168
Corresponding Author Zong-Xian Zhao, Department of Anorectal Surgery, Fuyang City People’s Hospital, No. 501 Sanqing Road, Yingzhou District, Fuyang 236000, Anhui Province, China. 461901580@qq.com
Key Words Chromatin assembly factor 1 subunit B; Left colorectal cancer; Immunotherapy; Chemosensitivity; Biomarker; Prognosis
Core Tip Accumulating evidence supports the notion that left-side colorectal cancer (CRC) and right-sided CRC represent distinct disease entities. Precise molecular subtyping of CRC is therefore an urgent unmet need to enable individualized precision treatment. Currently, the biological function of chromatin assembly factor 1 subunit B (CHAF1B) in CRC remains largely uncharacterized. In this study, elevated CHAF1B was an independent favorable prognostic biomarker for left-side CRC patients and correlated with enhanced cellular sensitivity to first-line chemotherapeutic agents. High CHAF1B expression was significantly associated with microsatellite instability-high status and high tumor mutational burden, as well as potential favorable therapeutic outcomes in patients receiving immunotherapy.
Publish Date 2026-11-19 06:51
Citation

Fan XJ, Wang FS, Yao Y, Xu S, Chen CQ, Zhao ZX. Chromatin assembly factor 1 subunit B expression correlates with favorable prognosis and potential therapeutic response prediction in left-sided colorectal cancer. World J Gastrointest Oncol 2026; 18(12): 125841

URL https://www.wjgnet.com/1948-5204/full/v18/i12/125841.htm
DOI https://doi.org/10.4251/wjgo.125841
Full Article (PDF) WJGO-18-125841-with-cover.pdf